1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Boehringer Ingelheim Vetmedica


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    1
    Views:
    1,506
  2. anonymous
    Replies:
    1
    Views:
    1,008
  3. anonymous
    Replies:
    2
    Views:
    1,003
  4. anonymous
    Replies:
    2
    Views:
    6,774
  5. Anonymous Mgr
    Replies:
    17
    Views:
    8,390
  6. anonymous
    Replies:
    14
    Views:
    5,002
  7. anonymous
    Replies:
    5
    Views:
    3,947
  8. anonymous
    Replies:
    0
    Views:
    1,587
  9. anonymous
    Replies:
    6
    Views:
    2,760
  10. anonymous
    Replies:
    0
    Views:
    2,759
  11. anonymous
    Replies:
    0
    Views:
    2,188
  12. anonymous
    Replies:
    0
    Views:
    2,401
  13. anonymous
    Replies:
    17
    Views:
    7,128
  14. anonymous
    Replies:
    72
    Views:
    26,423
  15. anonymous
    Replies:
    35
    Views:
    11,444
  16. anonymous
    Replies:
    16
    Views:
    6,100
  17. anonymous
    Replies:
    0
    Views:
    2,570
  18. anonymous
    Replies:
    20
    Views:
    6,210
  19. anonymous
    Replies:
    5
    Views:
    3,947
  20. anonymous
    Replies:
    8
    Views:
    4,381

Thread Display Options

Loading...